The Inclusion of Spillover Effects in Economic Evaluation: A Public Health Economics Perspective
- PMID: 30465229
- DOI: 10.1007/s40273-018-0748-9
The Inclusion of Spillover Effects in Economic Evaluation: A Public Health Economics Perspective
Comment on
-
Expanding the Scope of Costs and Benefits for Economic Evaluations in Health: Some Words of Caution.Pharmacoeconomics. 2019 Apr;37(4):457-460. doi: 10.1007/s40273-018-0729-z. Pharmacoeconomics. 2019. PMID: 30328562 No abstract available.
-
The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra.Pharmacoeconomics. 2019 Apr;37(4):451-456. doi: 10.1007/s40273-018-0730-6. Pharmacoeconomics. 2019. PMID: 30328563 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
